BTIG Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $25

Benzinga Newsdesk www.benzinga.com Positive 54.7%

Neg 0% Neu 0% Pos 54.7%

BTIG analyst Marie Thibault initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $25.